UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 18, 2018 5:05 P.M.

Form:	S-1
CIK: 0001492422 Company Name: Apellis Pharmaceuticals, Inc. File Number: 333-224303